Inhibition of NADPH oxidase by glucosylceramide confers chemoresistance

Brian M. Barth, Sally J. Gustafson, Megan M. Young, Todd E. Fox, Sriram S. Shanmugavelandy, James M. Kaiser, Myles C. Cabot, Mark Kester, Thomas B. Kuhn

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

The bioactive sphingolipid ceramide induces oxidative stress by disrupting mitochondrial function and stimulating NADPH oxidase (NOX) activity, both implicated in cell death mechanisms. Many anticancer chemotherapeutics (anthracyclines, Vinca alkaloids, paclitaxel and fenretinide), as well as physiological stimuli such as tumor necrosis factor α (TNFα), stimulate ceramide accumulation and increase oxidative stress in malignant cells. Consequently, ceramide metabolism in malignant cells and, in particular the upregulation of glucosylceramide synthase (GCS), has gained considerable interest in contributing to chemoresistance. We hypothesized that increases in GCS activity and thus glucosylceramide, the product of GCS activity, represents an important resistance mechanism in glioblastoma. In our study, we determined that increased GCS activity effectively blocked reactive oxygen species formation by NOX. We further showed, in both glioblastoma and neuroblastoma cells that glucosylceramide directly interfered with NOX assembly, hence delineating a direct resistance mechanism. Collectively, our findings indicated that pharmacological or molecular targeting of GCS, using non-toxic nanoliposome delivery systems, successfully augmented NOX activity, and improved the efficacy of known chemotherapeutic agents.

Original languageEnglish (US)
Pages (from-to)1126-1136
Number of pages11
JournalCancer Biology and Therapy
Volume10
Issue number11
DOIs
StatePublished - Dec 1 2010

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

Barth, B. M., Gustafson, S. J., Young, M. M., Fox, T. E., Shanmugavelandy, S. S., Kaiser, J. M., Cabot, M. C., Kester, M., & Kuhn, T. B. (2010). Inhibition of NADPH oxidase by glucosylceramide confers chemoresistance. Cancer Biology and Therapy, 10(11), 1126-1136. https://doi.org/10.4161/cbt.10.11.13438